Kelicef 100 DT Tablet contains Cefpodoxime Proxetil 100mg, a third-generation oral cephalosporin antibiotic with broad-spectrum antibacterial activity. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible formulation, facilitating ease of administration, especially in pediatric and geriatric populations. Kelicef 100 DT is rapidly absorbed from the gastrointestinal tract and converted to its active form, cefpodoxime, achieving effective plasma concentrations to combat susceptible pathogens. It is effective against a wide range of Gram-positive and Gram-negative bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Klebsiella species. Dosage should be individualized based on the severity of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, require immediate medical attention. Kelicef 100 DT should be used with caution in patients with a history of penicillin or cephalosporin allergy. Proper adherence to prescribed dosage and duration is essential to prevent resistance development.